PepGen Inc. (PEPG)
3.815
-0.12
(-2.93%)
USD |
NASDAQ |
Nov 20, 10:47
PepGen Cash from Investing (Quarterly) : 12.46M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 12.46M |
| June 30, 2026 | -3.516M |
| March 31, 2026 | -1.459M |
| December 31, 2025 | -66.24M |
| September 30, 2025 | 18.90M |
| June 30, 2025 | 14.96M |
| March 31, 2025 | 17.15M |
| December 31, 2024 | 26.50M |
| September 30, 2024 | -0.133M |
| June 30, 2024 | -52.74M |
| March 31, 2024 | -11.29M |
| December 31, 2023 | -29.59M |
| Date | Value |
|---|---|
| September 30, 2023 | -0.225M |
| June 30, 2023 | -1.009M |
| March 31, 2023 | -1.181M |
| December 31, 2022 | -1.102M |
| September 30, 2022 | -0.43M |
| June 30, 2022 | -0.609M |
| March 31, 2022 | -1.614M |
| December 31, 2021 | -0.156M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -0.305M |
| December 31, 2020 | -0.006M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -0.231M |
| IRulya Therapeutics, Inc. | -67.79M |
| Q32 Bio, Inc. | -0.052M |
| Bridgebio Oncology Therapeutics, Inc. | 50.34M |
| Oncolytics Biotech, Inc. | -0.0069M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.18M |
| Cash from Financing (Quarterly) | -0.086M |
| Free Cash Flow | -63.28M |
| Free Cash Flow Per Share (Quarterly) | -0.1902 |
| Free Cash Flow to Equity (Quarterly) | -12.69M |
| Free Cash Flow to Firm (Quarterly) | -13.18M |
| Free Cash Flow Yield | -23.95% |